Asthma Trial, Recruiting NCT06151405 Sponsor: Pennington Biomedical Research Center Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06151405
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old
  • People with a body mass index (a height-to-weight measurement) between 18.5 and 29.99
  • People who have been diagnosed with asthma by a specialist, with this recorded in their medical history
  • People whose asthma is partly controlled or uncontrolled, based on a standard asthma questionnaire score of 22 or below
  • People who own a smartphone or device that works with the ZEPHYRx app or platform
  • People whose asthma medications have not changed in the past 2 months

Who may not be able to join:

  • People who have diabetes or who take medications that lower blood sugar levels
  • People with a fasting blood sugar level of 126 mg/dL or higher, or triglyceride (a type of fat in the blood) levels of 400 mg/dL or higher, measured at the time of screening
  • People who currently smoke, or who have a significant smoking history (more than 10 pack-years, which is roughly smoking one pack per day for 10 years)
  • People with other significant lung or heart conditions, or serious health conditions such as chronic obstructive pulmonary disease (COPD), kidney failure, or liver disease
  • People with high blood pressure that is not well controlled, meaning a top reading of 160 or higher, or a bottom reading of 100 or higher
  • Women who are pregnant or breastfeeding
  • People with food preferences or allergies that would make it difficult to follow the study's required diet
  • People who did not meet the requirements during the trial's lead-in period (a preparatory phase before the main trial begins) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jacob T Mey, PhD, RD, Pennington Biomedical Research Center

Phone: 225-763-2644

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pennington Biomedical Research Center
Registry
ClinicalTrials.gov
Start date
17 July 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Asthma Control; Asthma Control; Asthma Control; Asthma Control; Lung Function; Lung Function; Lung Function; Lung Function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov